A Randomised, Double-Blind, Parallel-Group, Multicentre, Phase III Study to Evaluate the Effect of Ticagrelor versus Placebo in Reducing the Rate of Vaso-Occlusive Crises in Paediatric Patients with Sickle Cell Disease (HESTIA3)
2020-07-04
عنوان الدراسة
A Randomised, Double-Blind, Parallel-Group, Multicentre, Phase III Study to Evaluate the Effect of Ticagrelor versus Placebo in Reducing the Rate of Vaso-Occlusive Crises in Paediatric Patients with Sickle Cell Disease (HESTIA3)
داعم الدراسة
Astrazeneca
دواء الدراسة
Ticagrelor
رقم بروتوكول الدراسة
D5136C00009
حالة الدراسة
Ongoing
موقع الدراسة
King Fahad Medical City (Riyadh), King Khalid University Hospital (Riyadh)
مرحلة الدراسة
3
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.